InflaRx NV (IFRX)
1.24
+0.06
(+5.08%)
USD |
NASDAQ |
Nov 12, 16:00
1.24
0.00 (0.00%)
After-Hours: 20:00
InflaRx Shareholders Equity (Quarterly) : 163.68M for Sept. 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 163.68M |
| June 30, 2026 | 167.13M |
| March 31, 2026 | 42.50M |
| September 30, 2025 | 53.31M |
| June 30, 2025 | 66.96M |
| March 31, 2025 | 76.12M |
| September 30, 2024 | 72.86M |
| June 30, 2024 | 88.05M |
| March 31, 2024 | 102.34M |
| December 31, 2023 | 113.32M |
| September 30, 2023 | 124.92M |
| June 30, 2023 | 135.99M |
| March 31, 2023 | 85.37M |
| December 31, 2022 | 94.29M |
| September 30, 2022 | 97.42M |
| June 30, 2022 | 106.77M |
| March 31, 2022 | 105.83M |
| December 31, 2021 | 119.73M |
| Date | Value |
|---|---|
| September 30, 2021 | 133.54M |
| June 30, 2021 | 146.59M |
| March 31, 2021 | 163.19M |
| December 31, 2020 | 95.27M |
| September 30, 2020 | 105.18M |
| June 30, 2020 | 102.35M |
| March 31, 2020 | 111.40M |
| December 31, 2019 | 120.27M |
| September 30, 2019 | 134.26M |
| June 30, 2019 | 149.03M |
| March 31, 2019 | 163.90M |
| December 31, 2018 | 173.06M |
| September 30, 2018 | 184.17M |
| June 30, 2018 | 188.88M |
| March 31, 2018 | 137.78M |
| December 31, 2017 | 143.41M |
| September 30, 2017 | -42.73M |
| June 30, 2017 | -37.27M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| MediGene AG | -- |
| BioNTech SE | 20.12B |
| Immatics NV | 498.07M |
| Arrowhead Pharmaceuticals, Inc. | 465.53M |
| Oncolytics Biotech, Inc. | -6.167M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 183.23M |
| Total Liabilities (Quarterly) | 19.55M |
| Debt to Equity Ratio | 0.0056 |
| Current Ratio | 7.263 |
| Net Debt Paydown Yield | -0.01% |